Biotech

All Articles

Biogen containers SAGE-324 collaboration after vital trembling fail

.Biogen has administered the last ceremonies to its own collaboration along with Sage Therapies on S...

AbbVie Parkinson's drug from $8.7 B Cerevel purchase ratings

.On the same day that some Parkinson's illness medicines are actually being actually questioned, Abb...

Arch closes $3B-plus fund to cultivate biopharma startups

.On the heels of a $3 billion fund from Bain Financing Life Sciences, Arch Project Partners is showi...

Orion to use Aitia's 'electronic doubles' to find new cancer cells drugs

.Finnish biotech Orion has snooped possible in Aitia's "digital twin" tech to establish brand new ca...

Windtree's shock med rears blood pressure in latest period 2 win

.While Windtree Therapeutics has actually strained to increase the monetary roots required to make i...

2 cancer biotechs combine, producing global footprint

.OncoC4 is actually taking AcroImmune-- as well as its own internal professional production function...

Amgen files first period 3 win for $400M dermatitis medicine

.Amgen has discussed (PDF) the 1st phase 3 data on its own $400 million eczema drug, connecting the ...

Biogen, UCB file phase 3 lupus succeed after falling short earlier trial

.Biogen as well as UCB's bet one's bottom dollar advancing into phase 3 astride a broken research st...

Aptadir hopes brand-new RNA inhibitors can reverse complicated cancers

.Italian biotech Aptadir Therapeutics has released along with the guarantee that its pipe of preclin...

Wave surfs DMD results to regulatory authorities' doors, sending stockpile

.Wave Lifestyle Sciences has fulfilled its target in a Duchenne muscle dystrophy (DMD) research, pos...